Recruiting NCT07212166
A Study of Questionnaires in Adolescents and Young Adults With Cancer
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Patient-Reported Outcome Surveys, Spanish version of PRO-AYA and the cognitive interview.
- Who it may be relevant to
- Registry conditions: Adolescents and Young Adults With Cancer. Basic parameters: 15 years — 39 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Psychometric and Linguistic Validation of PRO-AYA: Patient-Reported Outcomes for Adolescents and Young Adults (15-39) With Cancer
Overview
The purpose of this study is to evaluate a questionnaire called PRO-AYA: Patient-Reported Outcomes for Adolescents and Young Adults.
Interventions
- Other Patient-Reported Outcome Surveys
PRO-AYA , Patient-Reported ECOG PS, EORTC QLQ-C30, Demographic/Clinical Characteristics - Other Spanish version of PRO-AYA and the cognitive interview
Revised Spanish PRO-AYA, Demographic/Clinical Characteristics
Primary outcome measures
- Test-retest reliability [Time frame: up to one month]
- Linguistically validate PRO-AYA or patients who prefer their healthcare be delivered in Spanish. (Cohort 2) [Time frame: up to a month]
Eligibility criteria
Inclusion criteria
- English- or Spanish proficient
o As assessed by two items: How well do you speak English? What is your preferred language for healthcare?
- Between the ages of 15-39
- Diagnosed with cancer or the recurrence of a cancer as per clinician report and/or received active treatment for cancer between the ages of 15-39
- Able to complete questionnaires by themselves or with assistance as per self-report
- For Cohort 1 ONLY:
- 3 months from last treatment without plan to initiate any form of cancer-directed treatment in the next 3 months OR
- On chronic cancer-directed therapy for the last 3 months without plan to change cancer-directed therapy in the next 3 months AND
- ECOG Performance Status (0-4) or KPS/Lansky Score (0-100)
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
United States · 7 centers
- Memorial Sloan Kettering Basking Ridge (Consent Only) — Basking Ridge
- Memorial Sloan Kettering Monmouth (Consent Only) — Middletown
- Memorial Sloan Kettering Bergen (Consent Only) — Montvale
- Memorial Sloan Kettering Commack (Consent Only) — Commack
- Memorial Sloan Kettering Westchester (Consent Only) — Harrison
- Memorial Sloan Kettering Cancer Center — New York
- Memorial Sloan Kettering Nassau (Consent Only) — Uniondale
Identifiers
NCT: NCT07212166 · 25-213